{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T02:42:09Z","timestamp":1768876929705,"version":"3.49.0"},"reference-count":20,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,6,22]],"date-time":"2017-06-22T00:00:00Z","timestamp":1498089600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Key Research and Development Program from Zhejiang Province","award":["2015C03032"],"award-info":[{"award-number":["2015C03032"]}]}],"content-domain":{"domain":["clinicalkey.jp","ijaaonline.com","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.ijantimicag.2017.03.011","type":"journal-article","created":{"date-parts":[[2017,6,22]],"date-time":"2017-06-22T19:32:02Z","timestamp":1498159922000},"page":"237-241","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"title":["In vitro antibacterial activity of fosfomycin combined with other antimicrobials against KPC-producing  Klebsiella pneumoniae"],"prefix":"10.1016","volume":"50","author":[{"given":"Wei","family":"Yu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhang","family":"Bao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beiwen","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinru","family":"Ji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lihua","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4845-5904","authenticated-orcid":false,"given":"Yonghong","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2017.03.011_bib0010","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1097\/QCO.0000000000000109","article-title":"Options for treating carbapenem-resistant Enterobacteriaceae","volume":"27","author":"Rafailidis","year":"2014","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2017.03.011_bib0015","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ijantimicag.2009.03.009","article-title":"Fosfomycin for the treatment of infections caused by multidrug-resistant non-fermenting Gram-negative bacilli: a systematic review of microbiological, animal and clinical studies","volume":"34","author":"Falagas","year":"2009","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2017.03.011_bib0020","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.diagmicrobio.2013.04.004","article-title":"In vitro activity of fosfomycin in combination with imipenem, meropenem, colistin and tigecycline against OXA 48-positive Klebsiella pneumoniae strains","volume":"76","author":"Evren","year":"2013","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2017.03.011_bib0025","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1007\/s10096-011-1360-5","article-title":"Synergy of fosfomycin with carbapenems, colistin, netilmicin, and tigecycline against multidrug-resistant Klebsiella pneumoniae, Escherichia coli, and Pseudomonas aeruginosa clinical isolates","volume":"31","author":"Samonis","year":"2012","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2017.03.011_bib0030","author":"Clinical and Laboratory Standards Institute"},{"key":"10.1016\/j.ijantimicag.2017.03.011_bib0035","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.diagmicrobio.2010.12.002","article-title":"Multiplex PCR for detection of acquired carbapenemase genes","volume":"70","author":"Poirel","year":"2011","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2017.03.011_bib0040","author":"European Committee on Antimicrobial Susceptibility Testing"},{"key":"10.1016\/j.ijantimicag.2017.03.011_bib0045","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1128\/AAC.04089-14","article-title":"In vitro activities of combinations of rifampin with other antimicrobials against multidrug-resistant Acinetobacter baumannii","volume":"59","author":"Bai","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2017.03.011_bib0050","author":"Clinical and Laboratory Standards Institute"},{"key":"10.1016\/j.ijantimicag.2017.03.011_bib0055","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1128\/AAC.00741-13","article-title":"Evaluation of double- and triple-antibiotic combinations for VIM- and NDM-producing Klebsiella pneumoniae by in vitro time\u2013kill experiments","volume":"58","author":"T\u00e4ngd\u00e9n","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2017.03.011_bib0060","doi-asserted-by":"crossref","first-page":"3042","DOI":"10.1093\/jac\/dkv221","article-title":"In vitro pharmacodynamics of fosfomycin against clinical isolates of Pseudomonas aeruginosa","volume":"70","author":"Walsh","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2017.03.011_bib0065","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1093\/jac\/dki375","article-title":"Pharmacokinetics of imipenem in healthy volunteers following administration by 2\u2009h or 0.5\u2009h infusion","volume":"56","author":"Jaruratanasirikul","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2017.03.011_bib0070","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1002\/phar.1197","article-title":"Comparative pharmacokinetics, pharmacodynamics, and tolerability of ertapenem 1 gram\/day administered as a rapid 5-minute infusion versus the standard 30-minute infusion in healthy adult volunteers","volume":"33","author":"Wiskirchen","year":"2013","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.ijantimicag.2017.03.011_bib0075","doi-asserted-by":"crossref","first-page":"7094","DOI":"10.1128\/AAC.01032-15","article-title":"Optimizing the initial amikacin dosage in adults","volume":"59","author":"White","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2017.03.011_bib0080","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1093\/jac\/dkp342","article-title":"Off-label use of antibiotics in hospitalized patients: focus on tigecycline","volume":"64","author":"Curcio","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2017.03.011_bib0085","series-title":"A novel mechanism of action for the synergistic antibacterial activity of colistin and fosfomycin","author":"Lahiri","year":"2015"},{"key":"10.1016\/j.ijantimicag.2017.03.011_bib0090","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1093\/jac\/dkp224","article-title":"Synergistic effects of aminoglycosides and fosfomycin on Pseudomonas aeruginosa in vitro and biofilm infections in a rat model","volume":"64","author":"Cai","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2017.03.011_bib0095","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1093\/jac\/dku341","article-title":"Prolonged treatment with large doses of fosfomycin plus vancomycin and amikacin in a case of bacteraemia due to methicillin-resistant Staphylococcus epidermidis and IMP-8 metallo-\u03b2-lactamase-producing Klebsiella oxytoca","volume":"70","author":"Vergara-L\u00f3pez","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2017.03.011_bib0100","first-page":"2923","article-title":"Therapeutic efficacy of amikacin combined with fosfomycin against bacteria producing KPC enzymes","volume":"24","author":"Zheng","year":"2014","journal-title":"Chin J Nosocomiol"},{"key":"10.1016\/j.ijantimicag.2017.03.011_bib0105","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1089\/jamp.2013.1100","article-title":"A randomized double-blind placebo-controlled dose-escalation phase 1 study of aerosolized amikacin and fosfomycin delivered via the PARI Investigational eFlow\u00ae Inline Nebulizer System in mechanically ventilated patients","volume":"27","author":"Montgomery","year":"2014","journal-title":"J Aerosol Med Pulm Drug Deliv"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857917301917?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857917301917?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,7,4]],"date-time":"2018-07-04T04:48:59Z","timestamp":1530679739000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857917301917"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":20,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["S0924857917301917"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2017.03.011","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In vitro antibacterial activity of fosfomycin combined with other antimicrobials against KPC-producing Klebsiella pneumoniae","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2017.03.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}